Prestige CEO Tightens Focus On OTCs, Considers Divesting Personal Care

Prestige Brands Holdings may divest its entire personal care segment to sharpen its focus on OTC drug and household products, new CEO Matt Mannelly says

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet